Detalhe da pesquisa
1.
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.
Blood
; 139(10): 1564-1574, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34587251
2.
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.
N Engl J Med
; 380(8): 720-728, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30786186
3.
Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia.
Am J Hematol
; 95(2): 178-187, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31821591
4.
A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia.
Acta Haematol
; 143(3): 244-249, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665725
5.
Ethnic and racial difference in Helicobacter pylori infection in patients with immune thrombocytopenia treated at a major urban medical center.
Platelets
; 30(3): 413-417, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-29580123
6.
Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
Oncologist
; 23(2): 247-255, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28951500
7.
Are Tpo agonists an option for ITP in pregnancy?
Blood
; 136(26): 2971-2972, 2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33367548
8.
Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia.
Haematologica
; 101(11): 1327-1332, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27515248
9.
Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab.
Transfusion
; 55(10): 2398-403, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25989361
10.
Approach to the management of incidental venous thromboembolic events in patients with cancer.
J Natl Compr Canc Netw
; 12(11): 1557-60, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25361802
11.
Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study.
Br J Haematol
; 162(5): 693-701, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23829485
12.
Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study).
Br J Haematol
; 160(4): 530-7, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23240761
13.
Predictive model of venous thromboembolism in endometrial cancer.
Gynecol Oncol
; 128(3): 544-51, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23262205
14.
Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study.
Ther Adv Hematol
; 14: 20406207231205431, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37869360
15.
The ITP syndrome: pathogenic and clinical diversity.
Blood
; 113(26): 6511-21, 2009 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19395674
16.
Corticosteroid overuse in adults with immune thrombocytopenia: Cause for concern.
Res Pract Thromb Haemost
; 5(6): e12592, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34466771
17.
Understanding Immune Thrombocytopenia: Looking Out of the Box.
Front Med (Lausanne)
; 8: 613192, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34249957
18.
Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method.
Res Pract Thromb Haemost
; 5(1): 69-80, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33537531
19.
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.
J Clin Oncol
; 38(5): 496-520, 2020 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31381464
20.
Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders.
Semin Hematol
; 46(1 Suppl 2): S33-6, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19245932